SEER, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
SEER, INC. (SEER) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.46 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-11
- SEER, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 273.32K shares, a 5.65% increase year-over-year.
- SEER, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 1.18M shares, a 173.24% increase year-over-year.
- SEER, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 26.90K shares, a 77.24% decline year-over-year.
- SEER, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 245.02K shares, a 41.57% decline year-over-year.
- SEER, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 964.27K shares, a 73.45% decline from fiscal 2024.
- SEER, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 3.63M shares, a 1.55% increase from fiscal 2023.
- SEER, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 3.58M shares, a 6.57% increase from fiscal 2022.
- SEER, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 3.36M shares, a 100.01% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 273.32K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 1.46M shares 10-Q · filed 2026-08-11 | 1.49M shares derived: sum of 3 quarters · filed 2026-08-11 | 1.73M shares derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 1.18M shares 10-Q · filed 2026-05-13 | 1.21M shares derived: sum of 2 quarters · filed 2026-05-13 | 1.46M shares derived: sum of 3 quarters · filed 2026-05-13 | 1.72M shares derived: sum of 4 quarters · filed 2026-05-13 |
| 2025-12-31 | 26.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 271.92K shares derived: sum of 2 quarters · filed 2026-03-02 | 530.62K shares derived: sum of 3 quarters · filed 2026-03-02 | 964.27K shares 10-K · filed 2026-03-02 |
| 2025-09-30 | 245.02K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 503.72K shares derived: sum of 2 quarters · filed 2025-11-06 | 937.37K shares 10-Q · filed 2025-11-06 | 1.06M shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 258.70K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | 692.35K shares 10-Q · filed 2025-08-06 | 810.55K shares derived: sum of 3 quarters · filed 2025-08-06 | 1.23M shares derived: sum of 4 quarters · filed 2025-08-06 |
| 2025-03-31 | 433.65K shares 10-Q · filed 2025-05-13 | 551.85K shares derived: sum of 2 quarters · filed 2025-05-13 | 971.17K shares derived: sum of 3 quarters · filed 2025-05-13 | 1.32M shares derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | 118.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 537.52K shares derived: sum of 2 quarters · filed 2025-03-03 | 886.12K shares derived: sum of 3 quarters · filed 2025-03-03 | 3.63M shares 10-K · filed 2025-03-03 |
| 2024-09-30 | 419.32K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | 767.92K shares derived: sum of 2 quarters · filed 2024-11-06 | 3.51M shares 10-Q · filed 2024-11-06 | 3.80M shares derived: sum of 4 quarters · filed 2024-11-06 |
| 2024-06-30 | 348.60K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 3.09M shares 10-Q · filed 2024-08-08 | 3.38M shares derived: sum of 3 quarters · filed 2024-08-08 | 3.41M shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 2.75M shares 10-Q · filed 2024-05-08 | 3.03M shares derived: sum of 2 quarters · filed 2024-05-08 | 3.06M shares derived: sum of 3 quarters · filed 2024-05-08 | 4.07M shares derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | 287.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-04 | 317.66K shares derived: sum of 2 quarters · filed 2024-03-04 | 1.33M shares derived: sum of 3 quarters · filed 2024-03-04 | 3.58M shares 10-K · filed 2024-03-04 |
| 2023-09-30 | 30.46K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 1.04M shares derived: sum of 2 quarters · filed 2023-11-07 | 3.29M shares 10-Q · filed 2023-11-07 | 3.72M shares derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | 1.01M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 3.26M shares 10-Q · filed 2023-08-08 | 3.68M shares derived: sum of 3 quarters · filed 2023-08-08 | 4.04M shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | 2.25M shares 10-Q · filed 2023-05-09 | 2.67M shares derived: sum of 2 quarters · filed 2023-05-09 | 3.03M shares derived: sum of 3 quarters · filed 2023-05-09 | 3.66M shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 425.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | 780.78K shares derived: sum of 2 quarters · filed 2023-03-06 | 1.41M shares derived: sum of 3 quarters · filed 2023-03-06 | 3.36M shares 10-K · filed 2023-03-06 |
| 2022-09-30 | 355.07K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 983.32K shares derived: sum of 2 quarters · filed 2022-11-08 | 2.93M shares 10-Q · filed 2022-11-08 | 3.22M shares derived: sum of 4 quarters · filed 2022-11-08 |
| 2022-06-30 | 628.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | 2.58M shares 10-Q · filed 2022-08-09 | 2.87M shares derived: sum of 3 quarters · filed 2022-08-09 | 3.24M shares derived: sum of 4 quarters · filed 2022-08-09 |
| 2022-03-31 | 1.95M shares 10-Q · filed 2022-05-06 | 2.24M shares derived: sum of 2 quarters · filed 2022-05-06 | 2.61M shares derived: sum of 3 quarters · filed 2022-05-06 | 2.86M shares derived: sum of 4 quarters · filed 2022-05-06 |
| 2021-12-31 | 293.81K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 662.34K shares derived: sum of 2 quarters · filed 2022-03-01 | 909.42K shares derived: sum of 3 quarters · filed 2022-03-01 | 1.68M shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 368.53K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 615.60K shares derived: sum of 2 quarters · filed 2021-11-09 | 1.38M shares 10-Q · filed 2021-11-09 | |
| 2021-06-30 | 247.07K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 1.02M shares 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | 768.62K shares 10-Q · filed 2021-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |